Two independent families with strongly suspected hereditary diffuse gastric cancer based on the probands' endoscopic findings

Clin J Gastroenterol. 2020 Oct;13(5):754-758. doi: 10.1007/s12328-020-01163-y. Epub 2020 Jun 27.

Abstract

Hereditary diffuse gastric cancer (HDGC) is the most famous of hereditary gastric cancer syndromes with an autosomal dominant inheritance pattern, and its diagnosis can be made by identifying a pathogenic germline variant in CDH1. We report two independent families that were strongly suspected of having HDGC based on endoscopic findings (multiple tiny, pale areas) obtained in the probands; the probands were pathologically diagnosed as having signet ring cell carcinoma (SRCC) and were genetically confirmed to have a pathogenic CDH1 germline variant. Although the updated International Gastric Cancer Linkage Consortium (IGCLC)'s clinical guidelines for HDGC (2015) state that screening/surveillance endoscopy should be performed (Cambridge protocol), the endoscopic findings obtained in the two presently reported families suggest that pale areas should be suspected as indicating the presence of SRCCs, and biopsies should be performed in addition to obtaining a precise family history in cases suspected of having HDGC.

Keywords: CDH1; Endoscopic findings; Gastric cancer; HDGC; Hereditary diffuse gastric cancer.

MeSH terms

  • Carcinoma, Signet Ring Cell* / diagnosis
  • Carcinoma, Signet Ring Cell* / genetics
  • Carcinoma, Signet Ring Cell* / surgery
  • Endoscopy
  • Gastrectomy
  • Genetic Predisposition to Disease
  • Germ-Line Mutation
  • Humans
  • Neoplastic Syndromes, Hereditary* / diagnosis
  • Neoplastic Syndromes, Hereditary* / genetics
  • Neoplastic Syndromes, Hereditary* / surgery
  • Stomach Neoplasms* / diagnosis
  • Stomach Neoplasms* / genetics
  • Stomach Neoplasms* / surgery